• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:王娟,郑兴,张思,王冠,戴玲,于樱姿,姚旭,郑自通.齐墩果酸二氟甲酯的合成及其抗纤维化作用[J].药学研究,2025,44(6):543-546[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2135次   下载 710次 本文二维码信息
码上扫一扫!
齐墩果酸二氟甲酯的合成及其抗纤维化作用
王娟1,郑兴2,3,张思3,王冠2,戴玲3,于樱姿2,姚旭2,郑自通4
字体:加大+|默认|缩小-
(1.长沙市第三医院<湖南大学附属长沙医院>药学部,湖南 长沙 410000;2.南华大学衡阳医学院药学院药物药理研究所,湖南 衡阳 421001;3.湖南科技职业学院药学院,湖南 长沙 410000;4.南华大学附属第二医院药学部,湖南 衡阳 421001)
摘要:
目的 评估新化合物齐墩果酸二氟甲酯(DFOA)对四氯化碳(CCl4)诱导小鼠肝纤维化损伤的保护作用。方法 制备DFOA,并确认其结构,将84只小鼠分为正常对照、肝纤维化模型及DFOA低、中、高剂量组和阳性对照组,CCl4建模,灌胃给药4周。检测血清肝功能指标[谷丙转氨酶(ALT)、谷草转氨酶(AST)、白蛋白(ALB)]并进行肝脏组织病理学分析。结果 DFOA可降低ALT和AST,提高ALB水平,减轻了肝脏损伤和纤维化。结论 DFOA对CCl4诱导的肝纤维化具有显著的保护作用,具有保肝、降转氨酶和抗纤维化潜力。
关键词:  齐墩果酸  小鼠  齐墩果酸二氟甲酯  肝纤维化
DOI:10.13506/j.cnki.jpr.2025.06.004
基金项目:中国科学院有机氟化学重点实验室项目(No.2018-10);湖南省自然科学基金项目(No.2020JJ6052、2021JJ80015);湖南省科技厅重点项目(No.2016DK2001);大学生创新创业训练计划项目(No.S202310555311)
出版日期:2025-06-25
Synthesis of gem-difluoromethylenated oleanolic acid and its anti-hepatic fibrosis effect
WANG Juan1,ZHENG Xing2,3,ZHANG Si3,WANG Guan2,DAI Ling3,YU Yingzi2,YAO Xu2,ZHENG Zitong4
(1.Department of Pharmacy, The Third Hospital of Changsha, Changsha 410000, China; 2. Institute of Pharmacy and Pharmacology, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, China; 3. School of Pharmaceutical Science,Hunan Vocational College of Science and Technology, Changsha 410000, China; 4. Department of Pharmacy, The Second Affiliated Hospital of South China University, Hengyang 421001, China)
Abstract:
Objective To assess the protective efficacy of the novel compound difluoromethyl oleanolic acid (DFOA) against liver fibrosis injury in mice, induced by carbon tetrachloride (CCl4).Methods To prepare DFOA and confirm its structure, 84 mice were divided into normal control, liver fibrosis model, and low, medium, and high-dose DFOA groups, as well as a positive control group. Liver fibrosis was induced using CCl4, and the mice were administered drugs by gavage for 4 weeks. Serum liver function indicators (ALT, AST, ALB) were tested, and histopathological analysis of liver tissue was performed. Results Treatment with DFOA led to a statistically significant decrease in ALT and AST levels in mice with liver fibrosis, accompanied by a notable increase in ALB levels. Compared to the model group, DFOA-treated mice exhibited marked improvements in liver injury and a reduced extent of fibrosis. Conclusion DFOA emerges as a promising agent with a notable protective effect against CCl4-induced liver fibrosis, highlighting its potential applications in hepatoprotection, transaminase reduction, and fibrosis antagonism.
Key words:  Oleanolic acid  Mice  Gem-difluoromethylenated oleanolic acid  Hepatic fibrosis
今日访问量:2470    总访问量:55338900
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司